Immunotherapies targeting melanoma post strong results, new data show

Immunotherapies targeting melanoma post strong results, new data show

STAT Plus: Immunotherapies targeting melanoma post encouraging results, new data show

By ADAM FEUERSTEIN

ANNE WESTON/FRANCIS CRICK INSTITUTE/WELLCOME

Iovance Biotherapeutics and Nektar Therapeutics presented updates on their melanoma programs at the Society for Immunotherapy of Cancer annual meeting.

READ MORE